top of page

Patent Portfolios Details
IPHatch Asia
HKUST 04
Pathological Condition Treatment
• HK Exclusive •
Require to set up a Hong Kong company
HKUST
US8389544
Title of Patent:
Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2
Isoquinolone compounds that are capable of modulating melatonin receptors and to pharmaceutical compositions containing such compounds for treating disorders or pathological conditions associated with melatonin receptors in mammalian subjects
Method to treat, prevent or ameliorate a pathological condition in mammal
Promising therapeutic agents used to treat insomnia and circadian-related disorders such as jet lag
Potential Areas of Applications:
Medicine
Healthcare
Cure Sleep Disorders
Pharmaceutical
Proposed Schemes:
Licensing
* Schemes are subject to the business model and are open for discussion.
IP Originated by

HKUST 03
bottom of page